Cargando…

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease

Alzheimer’s disease (AD), with main clinical features of progressive impairment in cognitive and behavioral functions, is the most common degenerative disease of the central nervous system. Recent evidence showed that microRNAs (miRNAs) played important roles in the pathological progression of AD. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Juanjuan, Yue, Dongxu, Zhou, Ya, Jia, Li, Wang, Hairong, Guo, Mengmeng, Xu, Hualin, Chen, Chao, Zhang, Jidong, Xu, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513952/ https://www.ncbi.nlm.nih.gov/pubmed/28769871 http://dx.doi.org/10.3389/fneur.2017.00342

Ejemplares similares

MicroRNA-7: expression and function in brain physiological and pathological processes
por: Zhao, Juanjuan, et al.
Publicado: (2020)

MicroRNA-7, synergizes with RORα, negatively controls the pathology of brain tissue inflammation
por: Yue, Dongxu, et al.
Publicado: (2020)

MicroRNAs expression profile in CCR6(+) regulatory T cells
por: Zhao, Juanjuan, et al.
Publicado: (2014)

MicroRNAs and the Regulation of Tau Metabolism
por: Hébert, Sébastien S., et al.
Publicado: (2012)

Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
por: Jia, Longfei, et al.
Publicado: (2021)

Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2020)

MicroRNAs in Alzheimer’s Disease
por: Wang, Mengli, et al.
Publicado: (2019)

MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4
por: Zhao, Juanjuan, et al.
Publicado: (2016)

Presymptomatic change in microRNAs modulates Tau pathology
por: Sharma, Salil, et al.
Publicado: (2018)

Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease
por: Yu, Chao-Chao, et al.
Publicado: (2019)

The Regulation of microRNAs in Alzheimer's Disease
por: Kou, Xianjuan, et al.
Publicado: (2020)

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
por: Cai, Yue, et al.
Publicado: (2023)

Mechanisms Controlling MicroRNA Expression in Tumor
por: Chen, Shipeng, et al.
Publicado: (2022)

Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
por: Wang, Hairong, et al.
Publicado: (2018)

MicroRNAs circulate around Alzheimer's disease
por: Smith-Vikos, Thalyana, et al.
Publicado: (2013)

The emerging role of microRNAs in Alzheimer's disease
por: Femminella, Grazia D., et al.
Publicado: (2015)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

MicroRNAs as Candidate Biomarkers for Alzheimer’s Disease
por: Kanach, Colin, et al.
Publicado: (2021)

MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease
por: Li, Wanran, et al.
Publicado: (2023)

MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer’s disease
por: Wang, Gang, et al.
Publicado: (2016)

Microglial microRNAs mediate sex-specific responses to tau pathology
por: Kodama, Lay, et al.
Publicado: (2019)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

MicroRNA‐128 suppresses tau phosphorylation and reduces amyloid‐beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease
por: Li, Siwen, et al.
Publicado: (2023)

A new perspective on Alzheimer’s disease: microRNAs and circular RNAs
por: Abidin, Shahidee Zainal, et al.
Publicado: (2023)

The Role of microRNAs in Alzheimer’s Disease and Their Therapeutic Potentials
por: Miya Shaik, Munvar, et al.
Publicado: (2018)

The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease
por: Samadian, Mohammad, et al.
Publicado: (2021)

MicroRNAs in Learning and Memory and Their Impact on Alzheimer’s Disease
por: Wang, I-Fang, et al.
Publicado: (2022)

Targeted Expression of miR-7 Operated by TTF-1 Promoter Inhibited the Growth of Human Lung Cancer through the NDUFA4 Pathway
por: Lei, Liangyu, et al.
Publicado: (2017)

MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases
por: Chen, Chao, et al.
Publicado: (2023)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2018)

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2020)

Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease
por: Jonaitis, Erin M, et al.
Publicado: (2023)

MicroRNAs in Ocular Infection
por: Xu, Shunbin, et al.
Publicado: (2019)

Inhibitory Effects of Macelignan on Tau Phosphorylation and Aβ Aggregation in the Cell Model of Alzheimer's Disease
por: Gu, Liang, et al.
Publicado: (2022)

MicroRNAs as potential therapeutics for treating spinal cord injury
por: Yan, Hualin, et al.
Publicado: (2012)

Circulating microRNAs in Alzheimer’s disease: the search for novel biomarkers
por: Dorval, Véronique, et al.
Publicado: (2013)

MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
por: Angelucci, Francesco, et al.
Publicado: (2019)

In silico Analysis of Polymorphisms in microRNAs Deregulated in Alzheimer Disease
por: Moraghebi, Mahta, et al.
Publicado: (2021)

RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs
por: Nunomura, Akihiko, et al.
Publicado: (2020)

Synaptosome microRNAs regulate synapse functions in Alzheimer’s disease
por: Kumar, Subodh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dm0gb0sjt1blnr7jataui5gj1c